Development of a novel dalotuzumab/AKT inhibitor combination therapy for the treatment of cetuximab refractory colorectal cancer (CRC)

Autor:	C. Winter, A. Seeley, S. Jha, G. Naumov, R. S. Wexler, Andrew Bloecher, Sriram Sathyanarayanan, S. Howard, John F. Reilly, Erin Valentine, H. Keihack
Rok vydání:	2011
Předmět:	Oncology Cancer Research medicine.medical_specialty Cetuximab Combination therapy Colorectal cancer business.industry Dalotuzumab Akt inhibitor medicine.disease Refractory Internal medicine medicine In patient business medicine.drug
Zdroj:	Journal of Clinical Oncology. 29:e13590-e13590
ISSN:	1527-7755 0732-183X
Popis:	e13590 Background: Rational combination of 2 or more investigational compounds is a novel concept in oncology. We have entered phase I clinical development in patients with solid tumors with novel ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bdad4e95dd050c257dd11574fa4c59ba https://doi.org/10.1200/jco.2011.29.15_suppl.e13590 Zobrazit plný text záznamu